- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Mucosal Melanoma in New Zealand
Total 1862 results
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI); NCIC Clinical Trials Group; Children's Oncology... and other collaboratorsActive, not recruitingMelanoma (Skin)United States, Canada, Australia, South Africa
-
Saint John's Cancer InstituteMelanoma Research AllianceTerminatedStage IV Resectable MelanomaUnited States, Australia, Israel, Italy, Netherlands
-
NYU Langone HealthActive, not recruiting
-
Bristol-Myers SquibbRoche-GenentechTerminated
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterCompleted
-
NYU Langone HealthBristol-Myers Squibb; Daiichi Sankyo, Inc.CompletedMelanomaUnited States
-
Novartis PharmaceuticalsCompletedUveal MelanomaUnited Kingdom, France, Netherlands, United States
-
National Cancer Institute (NCI)Active, not recruitingStage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Icahn School of Medicine at Mount SinaiBristol-Myers SquibbTerminatedMelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Bristol-Myers SquibbTerminatedMalignant MelanomaGermany, United States, Mexico, Denmark, France, Belgium, United Kingdom, Spain
-
BioVex LimitedSymbion Research InternationalCompletedMelanomaUnited Kingdom, United States
-
Aura BiosciencesRecruitingChoroidal Melanoma | Indeterminate Lesions of EyeUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMelanoma | Solid Tumor | Metastatic Melanoma | NeoplasmUnited States, United Kingdom
-
AdaptimmuneTerminated
-
PfizerCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedMelanoma | Survivors | Psychological FactorsUnited States
-
NCIC Clinical Trials GroupCompleted
-
Clinigen, Inc.Johns Hopkins University; M.D. Anderson Cancer CenterTerminatedMetastatic MelanomaUnited States
-
Hoffmann-La RocheRecruitingMelanomaBrazil, Czechia, Spain, Turkey, New Zealand, Canada, Australia, Poland, Slovakia, Greece
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingRefractory Melanoma | HLA-A2 Positive Cells PresentUnited States
-
Yale UniversityCompleted
-
Bristol-Myers SquibbCompleted
-
Georgetown UniversityExelixis; Hackensack Meridian Health; MedStar Franklin Square Medical CenterSuspendedMelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia, Brazil, Spain, South Africa, Ukraine, Bosnia and Herzegovina
-
AmgenCompletedMelanomaUnited States, Canada
-
Miltenyi Biomedicine GmbHDLR German Aerospace CenterTerminated
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Terminated
-
BeiGeneRecruitingSolid Tumor | Advanced Solid TumorUnited States, New Zealand, Australia, China
-
BioNTech SERegeneron PharmaceuticalsActive, not recruitingUnresectable Melanoma | Melanoma Stage IV | Melanoma Stage IIIUnited States, Spain, Germany, Italy, Australia, United Kingdom, Poland
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute Australia; Cancer Council New South WalesActive, not recruitingMetastatic Melanoma to the Groin Lymph NodesUnited Kingdom, Slovenia, Australia, Brazil, Netherlands, Italy
-
CytomX TherapeuticsTerminatedSolid Tumor | Unresectable or Metastatic MelanomaKorea, Republic of, United States, Netherlands, Spain, Australia
-
Eisai Inc.CompletedStage IV Melanoma | Unresectable Stage IIIUnited States, United Kingdom, Australia, Germany
-
Array Biopharma, now a wholly owned subsidiary...TerminatedUveal MelanomaUnited States, France, Germany, Netherlands, Spain, United Kingdom
-
Memorial Sloan Kettering Cancer CenterRecruitingMelanoma | Breast CancerUnited States, Germany
-
Bristol-Myers SquibbCompleted
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedMelanomaAustralia, United States
-
Ruhr University of BochumCompletedCutaneous Melanoma | NeviGermany
-
Bristol-Myers SquibbCompleted
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Recurrent Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV MelanomaUnited States
-
Bristol-Myers SquibbCompletedHigh Risk Stage III MelanomaItaly, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Advanced Malignant Solid Neoplasm | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Pathologic Stage... and other conditionsUnited States
-
Bristol-Myers SquibbCompletedUnresectable or Metastatic MelanomaUnited States, Germany, Italy, United Kingdom, Canada, Denmark, Netherlands, Spain, Belgium, France, Switzerland, Israel, Austria, Brazil
-
NewLink Genetics CorporationTerminated
-
National Cancer Institute (NCI)Active, not recruitingStage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Melanoma of Unknown Primary | Stage IIIB Cutaneous Melanoma AJCC v7United States, Canada